Literature DB >> 16829155

Leber's hereditary optic neuropathy: a multifactorial disease.

May-Yung Yen1, An-Guor Wang, Yau-Huei Wei.   

Abstract

Leber's hereditary optic neuropathy (LHON) is a maternally transmitted disease characterized by acute or subacute visual loss predominantly affecting young men. The majority of LHON cases are caused by one of the three primary mitochondrial DNA (mtDNA) mutations: G3460A/ND1, G11778A/ND4, or T14484C/ND6. Although the primary etiological factor of LHON is a mtDNA mutation, the presence of a primary mtDNA mutation does not necessarily lead to visual loss. The pathogenesis of LHON remains unclear. The marked incomplete penetrance and gender bias indicate that additional genetic (nuclear or mitochondrial) and epigenetic factors may also be involved. Deficiency in respiratory chain function and reactive oxygen species (ROS) are believed to play a pivotal role in the pathophysiology of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16829155     DOI: 10.1016/j.preteyeres.2006.05.002

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  46 in total

1.  [Leber's hereditary optic neuropathy].

Authors:  B Leo-Kottler; B Wissinger
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

2.  Molecular characterization of six Chinese families with m.3460G>A and Leber hereditary optic neuropathy.

Authors:  Dandan Yu; Xiaoyun Jia; A-Mei Zhang; Xiangming Guo; Ya-Ping Zhang; Qingjiong Zhang; Yong-Gang Yao
Journal:  Neurogenetics       Date:  2010-03-16       Impact factor: 2.660

3.  Enrichment of longevity phenotype in mtDNA haplogroups D4b2b, D4a, and D5 in the Japanese population.

Authors:  Gabriela Alexe; Noriyuki Fuku; Erhan Bilal; Hitomi Ueno; Yutaka Nishigaki; Yasunori Fujita; Masafumi Ito; Yasumichi Arai; Nobuyoshi Hirose; Gyan Bhanot; Masashi Tanaka
Journal:  Hum Genet       Date:  2007-02-17       Impact factor: 4.132

Review 4.  Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration.

Authors:  Romana Fato; Christian Bergamini; Serena Leoni; Paola Strocchi; Giorgio Lenaz
Journal:  Neurochem Res       Date:  2008-06-06       Impact factor: 3.996

5.  Mitochondrial haplotypes may modulate the phenotypic manifestation of the LHON-associated ND1 G3460A mutation in Chinese families.

Authors:  Yanchun Ji; Min Liang; Juanjuan Zhang; Minglian Zhang; Jinping Zhu; Xiangjuan Meng; Sai Zhang; Min Gao; Fuxin Zhao; Qi-Ping Wei; Pingping Jiang; Yi Tong; Xiaoling Liu; Jun Qin Mo; Min-Xin Guan
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

6.  Long-term evaluation of Leber's hereditary optic neuropathy-like symptoms in rotenone administered rats.

Authors:  Li Zhang; Laura Liu; Ann L Philip; Juan C Martinez; Juan C Guttierez; Mathieu Marella; Gaurav Patki; Akemi Matsuno-Yagi; Takao Yagi; Biju B Thomas
Journal:  Neurosci Lett       Date:  2014-12-03       Impact factor: 3.046

7.  Multiplex expression cloning of blood-brain barrier membrane proteins.

Authors:  Nitin Agarwal; Eric V Shusta
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

8.  Identification of novel mitochondrial mutations in Leber's hereditary optic neuropathy.

Authors:  Manoj Kumar; Mukesh Tanwar; Rohit Saxena; Pradeep Sharma; Rima Dada
Journal:  Mol Vis       Date:  2010-04-30       Impact factor: 2.367

9.  Mitochondrial DNA sequence variation and haplogroup distribution in Chinese patients with LHON and m.14484T>C.

Authors:  Dandan Yu; Xiaoyun Jia; A-Mei Zhang; Shiqiang Li; Yang Zou; Qingjiong Zhang; Yong-Gang Yao
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

10.  OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background.

Authors:  Denis Pierron; Marc Ferré; Christophe Rocher; Arnaud Chevrollier; Pascal Murail; Didier Thoraval; Patrizia Amati-Bonneau; Pascal Reynier; Thierry Letellier
Journal:  BMC Med Genet       Date:  2009-07-20       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.